Drug contains same active ingredient as Ozempic, which is prescribed for type 2 diabetes and is by far the best-selling drug ...

One of largest U.S. telehealth providers expects to ride wave of exploding demand for weight-loss drug semaglutide when it ...

The WHO issued guideline on the use of GLP-1 therapies for obesity, conditionally recommending them as part of long-term treatment.

As the World Health Organization conditionally recommends the use of GLP-1 medications to treat obesity, a Halifax-based ...

With shortages of Ozempic at U.S. pharmacies, some Americans have been turning to Canada and Mexico to buy the medication, a Type 2 diabetes treatment many people are using off-label to lose weight.

The World Health Organization has issued its first guidelines for the use of GLP-1s, such as Ozempic, to treat obesity. The ...

OneSource anticipates leading the generics market for semaglutide as multiple patents expire, expanding its capacity and ...

(Reuters) -Canada has approved Novo Nordisk's diabetes drug, Ozempic, to cut chronic kidney disease progression and reduce the risk of kidney failure and heart-related deaths in type-2 diabetes ...

Health Canada on Tuesday approved Novo Nordisk's (NYSE:NVO) Ozempic (semaglutide) to reduce the risk of kidney disease and cardiovascular deaths in adults with type 2 diabetes. The approval makes ...

If you visit a fast-food chain in the next few years, expect the menu to look a little less gluttonous.

Almost two-thirds of adults in Canada are overweight or living with obesity, according to the U.S. telehealth company ...